BridgeMD
Compares treatment options for Distal Radius Fracture
Official title "Supracondylar Radial Nerve Block Guided by Ultrasound Versus Hematoma Block for Analgesic Management in Closed Reduction of Distal Radius Fractures"
ClinicalTrials.gov ID: NCT06857110
What this study is testing
What is 5 mg of intramuscular diclofenac?
5 mg of intramuscular diclofenac is an investigational medicine, given as an injection into a muscle, being studied as a potential treatment for distal radius fracture.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Non-surgical treatment with closed reduction and immobilization using a splint or cast is the preferred approach for stable distal radius fractures, particularly in elderly patients. It is also the initial intervention for displaced fractures with a surgical indication before the procedure, aiming to reduce edema, manage pain, and prevent associated complications.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients over 18 years old with skeletal maturity evidenced in the initial radiographs.
- Patients with a radiological diagnosis of distal radius fracture
- Patients whose clinical condition is considered acute (duration of symptoms less than one week).
- Patients who have an indication for closed reduction as a definitive or initial management of their distal radius fracture
- Patients treated at San Ignacio University Hospital in Bogotá, Colombia
You likely can't join if
- Patients with bilateral distal radius fractures
- Patients with open distal radius fractures.
- Patients with another fracture in the same limb
- Patients in a state of intoxication or under the influence of psychoactive substances.
- Patients with hemodynamic instability that prevents prioritizing closed reduction as management.
- Patients with a known allergy to local anesthetics
See the full eligibility criteria
- Patients over 18 years old with skeletal maturity evidenced in the initial radiographs.
- Patients with a radiological diagnosis of distal radius fracture
- Patients whose clinical condition is considered acute (duration of symptoms less than one week).
- Patients who have an indication for closed reduction as a definitive or initial management of their distal radius fracture
- Patients treated at San Ignacio University Hospital in Bogotá, Colombia
- Patients with bilateral distal radius fractures
- Patients with open distal radius fractures.
- Patients with another fracture in the same limb
- Patients in a state of intoxication or under the influence of psychoactive substances.
- Patients with hemodynamic instability that prevents prioritizing closed reduction as management.
- Patients with a known allergy to local anesthetics
- Patients on full-dose anticoagulant therapy.
- Patients who refuse to participate in the study
- Patients with cognitive, visual, or auditory impairments that prevent the proper completion of questionnaires
The study team makes the final eligibility decision.
Where it's taking place
- Bogotá, Bogota D.C., Colombia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bogotá, Bogota D.C., Colombia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.